Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

GALDERMA LABS LP

  • FDA Approval
  • Dec. 13, 2024, 20:37 UTC
  • 34

FDA approve NEMOLIZUMAB-ILTO

Comment Full text

PFIZER

  • FDA Approval
  • Dec. 13, 2024, 19:13 UTC
  • 42

FDA approve RIMEGEPANT SULFATE

Comment Full text

DERMAVANT SCI

  • FDA Approval
  • Dec. 13, 2024, 19:13 UTC
  • 39

FDA approve TAPINAROF

Comment Full text

ALEMBIC

  • FDA Approval
  • Dec. 13, 2024, 09:45 UTC
  • 36

FDA approve ACETAZOLAMIDE

Comment Full text

NOVITIUM PHARMA

  • FDA Approval
  • Dec. 13, 2024, 09:45 UTC
  • 27

FDA approve DIAZOXIDE

Comment Full text

RISING

  • FDA Approval
  • Dec. 13, 2024, 09:45 UTC
  • 35

FDA approve CYTARABINE

Comment Full text

ORBION PHARMS

  • FDA Approval
  • Dec. 13, 2024, 09:45 UTC
  • 36

FDA approve ARIPIPRAZOLE

Comment Full text

FRESENIUS KABI USA

  • FDA Approval
  • Dec. 13, 2024, 09:45 UTC
  • 39

FDA approve CYTARABINE

Comment Full text

APNAR PHARMA LP

  • FDA Approval
  • Dec. 13, 2024, 09:45 UTC
  • 37

FDA approve TERAZOSIN HYDROCHLORIDE

Comment Full text

MYLAN LABS LTD

  • FDA Approval
  • Dec. 13, 2024, 09:45 UTC
  • 33

FDA approve GLUCAGON

Comment Full text
  • Previous
  • 125
  • 126
  • 127
  • 128
  • 129
  • Next

Search

News categories

  • Technical Exchange News(9387)
  • Event(407)
  • SEC News(153622)
  • FDA Approval(8775)
  • Company Report(721)
  • Business News(104809)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin